Skip to main content
logo
GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
8.61
+2.43 (39.32%)
At close: Sep 11, 2026, 4:00 PM EDT
8.66
+0.05 (0.58%)
After-hours: Sep 11, 2026, 7:57 PM EDT

GT Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1687112993
Market Cap Growth
454.85%22.55%-35.48%-63.37%-69.01%159.69%
Enterprise Value
1160-5857
Last Close Price
8.6119.6376.25191.25664.282287.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
4.311.44-4.081.412.464.25
P/TBV Ratio
4.351.44-1.412.464.25

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
---0.010.020.00
Net Debt / Equity Ratio
-1.39-1.182.37-1.86-1.39-1.46
Net Debt / FCF Ratio
0.340.530.311.571.072.05
Quick Ratio
2.242.940.672.113.343.12
Current Ratio
2.613.500.722.123.353.14
Return on Equity (ROE)
-113.52%-1377.41%-453.39%-79.09%-124.15%-
Return on Assets (ROA)
-158.16%-125.85%-97.89%-55.02%-54.33%-190.04%
Return on Capital Employed (ROCE)
-457.70%-214.70%860.10%-181.60%-180.20%-262.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-73.25%-339.51%-193.14%-71.93%-72.42%-62.35%
FCF Yield
-92.86%-154.63%-189.36%-83.81%-52.77%-16.77%
Buyback Yield / Dilution
-795.21%-190.57%-40.78%-26.87%-13.19%-
SEC Filings: 10-K · 10-Q